Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

ResMed CEO Mick Farrell Balances Career, Family, and Bringing Tech, Software, and Data into Medtech

September 11, 2018

Mick Farrell’s father questioned his son’s double degree from MIT when he didn’t immediately see the opportunity facing the sleep apnea company. But the younger Farrell quickly came around and helped build ResMed into a $15 billion company, with the last five years at the helm as CEO. Today, however, Farrell has ResMed beginning to take a very different path, migrating away from pure medical device sales and into selling software and other tech services to physicians.

Mick Farrell

CEO

ResMed

Mick Farrell was appointed ResMed’s CEO in March 2013. He joined the company in 2000, serving as president of the Americas region from 2011 to 2013, senior vice president of the global sleep apnea business unit from 2007 to 2011, and various senior roles in marketing and business development. Before joining ResMed, Mick worked in management consulting, biotechnology, chemicals and metals manufacturing at Arthur D. Little, Genzyme Corporation (now part of Sanofi), The Dow Chemical Company, and BHP Billiton. Mick serves on the board of directors of ResMed, the Advanced Medical Technology Association (AdvaMed) and Zimmer Biomet (NYSE: ZBH), a multibillion dollar public company that provides implantable musculoskeletal medical devices for patients globally. He is also a member of two committees at Zimmer Biomet: Nominating and Governance as well as Compensation and Management Development. He also volunteers as a trustee for non-profit organizations: UC San Diego Foundation, Rady Children’s Hospital, the La Jolla Playhouse, and the Museum of Man in San Diego. Mick holds a bachelor of engineering with first-class honors from the University of New South Wales, a Master of Science in chemical engineering from the Massachusetts Institute of Technology, and a Master of Business Administration from the MIT Sloan School of Management.